Antibody Drug Conjugates (ADC) Drug Development and Manufacturing Trends, Challenges and Solutions
Expediting Biologics Drug Development: Strategies to Accelerate Preclinical Development Timelines
GMP Inspection Completed by ANVISA at WuXi Biologics DS facility

WuXi Biologics Launched Biologics Integrated Innovation Center in Hangzhou for next-generation biological products based on microbial fermentation and viral production
_______________________________

WuXi Biologics Unveils New Process Development and Testing Facility in King of Prussia, Pennsylvania
_______________________________

WuXi Biologics Signs Lease for a Clinical Manufacturing Facility in the United States (Cranbury, NJ)
_______________________________

WuXi Biologics Closes Land Deal to Build State-of-the-Art Biologics Production Facility in Worcester, MA
WuXi Biologics standardizes a remarkable 12 month “DNA to IND” timeline through its streamlined development platform
Our Regulatory Affairs team provides a quarterly summary of updates organized by agency and by topic. These updates support your efforts to stay current in our ever-changing regulatory environment.
For more information - See this Podcast
Arcus Biosciences Expands Strategic Relationship with WuXi Biologics to Develop a Best-in-Class anti-CD39 Antibody for the Treatment of Cancer
_______________________________

Tubulis Forms Strategic Partnership with WuXi Biologics and WuXi STA to Advance New Generation of Antibody-Drug Conjugates towards Clinical Evaluation
_______________________________

WuXi Biologics and AC Immune Strengthen Strategic Partnership to Accelerate AC Immune’s Anti-TDP-43 Antibodies into Clinical Development
______________________________

WuXi Biologics and AB2 Bio Announce Collaboration to Accelerate Commercial-Scale Manufacturing of Tadekinig alfa
Meet with us anytime between January 11-15, 2021 via the BIO One-on-One Partnering portal to discuss your 2021 drug development needs.
See the full agenda and register for the WuXi Global Forum 2021, which will premiere virtually January 11-13, 2021.
To read more about WuXi Biologics visit our Newsletter Archive